| Code | Description | Claims | Beneficiaries | Total Paid |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,578 |
2,438 |
$87K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,178 |
2,010 |
$48K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,389 |
1,332 |
$36K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
3,606 |
3,151 |
$36K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,526 |
4,039 |
$28K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,691 |
1,400 |
$23K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
57 |
47 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,766 |
4,240 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
319 |
298 |
$427.90 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
82 |
82 |
$12.56 |
| 99000 |
|
13 |
12 |
$0.00 |